Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury.
ABANDONED SECTION 36
on 22 Jul 2008
ONZAGRIF
THERATECHNOLOGIES INC.
1350033 · 04 Jun 2007
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment and traumatic brain injury.
Pharmaceutical preparations for the treatment of lipodystrophy, obesit...
